SE7413710L - - Google Patents
Info
- Publication number
- SE7413710L SE7413710L SE7413710A SE7413710A SE7413710L SE 7413710 L SE7413710 L SE 7413710L SE 7413710 A SE7413710 A SE 7413710A SE 7413710 A SE7413710 A SE 7413710A SE 7413710 L SE7413710 L SE 7413710L
- Authority
- SE
- Sweden
- Prior art keywords
- glycyl
- radical
- optionally substituted
- amino acid
- benzene ring
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 abstract 2
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical class C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000000405 phenylalanyl group Chemical group 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 101000904177 Clupea pallasii Gonadoliberin-1 Proteins 0.000 abstract 1
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 abstract 1
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 125000001980 alanyl group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 125000001942 asparaginyl group Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical group NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 abstract 1
- -1 heterocyclic amino acid Chemical class 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 150000002739 metals Chemical class 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/13—Luteinizing hormone-releasing hormone; related peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5081173 | 1973-11-01 | ||
| GB4391774A GB1501855A (en) | 1974-10-10 | 1974-10-10 | Nona-and decapeptide amides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE7413710L true SE7413710L (enExample) | 1975-05-02 |
Family
ID=26265264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7413710A SE7413710L (enExample) | 1973-11-01 | 1974-10-31 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3992365A (enExample) |
| JP (1) | JPS5088069A (enExample) |
| AU (1) | AU497418B2 (enExample) |
| CA (1) | CA1030526A (enExample) |
| DE (1) | DE2451841A1 (enExample) |
| DK (1) | DK568274A (enExample) |
| FR (1) | FR2249677B1 (enExample) |
| IE (1) | IE40257B1 (enExample) |
| NL (1) | NL7414241A (enExample) |
| SE (1) | SE7413710L (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4083967A (en) * | 1973-11-01 | 1978-04-11 | Burroughs Wellcome Co. | Nona- and decapeptides |
| US4089946A (en) * | 1976-06-07 | 1978-05-16 | American Home Products Corporation | Claudogenic-interceptive nonapeptides |
| US4256737A (en) * | 1979-06-11 | 1981-03-17 | Syntex (U.S.A.) Inc. | Long acting depot injectable formulations for LH-RH analogues |
| DE3020941A1 (de) * | 1980-06-03 | 1981-12-17 | Hoechst Ag, 6000 Frankfurt | Nonapeptid, verfahren zu seiner herstellung, dieses enthaltendes mittel und seine verwendung |
| US4318905A (en) * | 1980-06-23 | 1982-03-09 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide agonists of luteinizing hormone releasing hormone containing heterocyclic amino acid residues |
| US4443368A (en) * | 1982-11-01 | 1984-04-17 | The Salk Institute For Biological Studies | Peptides affecting gonadal function |
| HU189394B (en) * | 1983-12-23 | 1986-06-30 | Koezponti Valto- Es Hitelbank Rt Innovacios Alap,Hu | Method for producing spermatozoa suitable for fertilization from mature fishes |
| HU194280B (en) * | 1985-10-22 | 1988-01-28 | Richter Gedeon Vegyeszet | Process for producing new gonadoliberin analogues of high effectivity and pharmaceutical compositions containing them |
| US4705778A (en) * | 1985-10-22 | 1987-11-10 | Sri International | Orally active LHRH analogs |
| US6413536B1 (en) | 1995-06-07 | 2002-07-02 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system and medical or surgical device |
| US7833543B2 (en) * | 1995-06-07 | 2010-11-16 | Durect Corporation | High viscosity liquid controlled delivery system and medical or surgical device |
| US20060025328A1 (en) * | 1997-05-28 | 2006-02-02 | Burns Patrick J | Compositions suitable for controlled release of the hormone GnRH and its analogs |
| US6051558A (en) * | 1997-05-28 | 2000-04-18 | Southern Biosystems, Inc. | Compositions suitable for controlled release of the hormone GnRH and its analogs |
| US20050020524A1 (en) * | 1999-04-15 | 2005-01-27 | Monash University | Hematopoietic stem cell gene therapy |
| US20040265285A1 (en) * | 1999-04-15 | 2004-12-30 | Monash University | Normalization of defective T cell responsiveness through manipulation of thymic regeneration |
| US20040258672A1 (en) * | 1999-04-15 | 2004-12-23 | Monash University | Graft acceptance through manipulation of thymic regeneration |
| US20040259803A1 (en) * | 1999-04-15 | 2004-12-23 | Monash University | Disease prevention by reactivation of the thymus |
| US20040241842A1 (en) * | 1999-04-15 | 2004-12-02 | Monash University | Stimulation of thymus for vaccination development |
| US20070274946A1 (en) * | 1999-04-15 | 2007-11-29 | Norwood Immunoloty, Ltd. | Tolerance to Graft Prior to Thymic Reactivation |
| AUPR074500A0 (en) * | 2000-10-13 | 2000-11-09 | Monash University | Treatment of t cell disorders |
| US20060088512A1 (en) * | 2001-10-15 | 2006-04-27 | Monash University | Treatment of T cell disorders |
| US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| EP2218448B1 (en) | 2002-12-13 | 2015-09-23 | Durect Corporation | Oral drug delivery system comprising high viscosity liquid carrier materials |
| US20080279812A1 (en) * | 2003-12-05 | 2008-11-13 | Norwood Immunology, Ltd. | Disease Prevention and Vaccination Prior to Thymic Reactivation |
| DK2767292T3 (en) | 2004-09-17 | 2016-12-19 | Durect Corp | RENEWABLE local anesthetic COMPOSITION CONTAINING SAIB |
| US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
| AU2007325918B2 (en) | 2006-11-03 | 2013-10-17 | Durect Corporation | Transdermal delivery systems comprising bupivacaine |
| EP2067471B1 (en) | 2007-12-06 | 2018-02-14 | Durect Corporation | Oral pharmaceutical dosage forms |
| US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
| CA2905131A1 (en) | 2013-03-15 | 2014-09-18 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| CN109475505A (zh) | 2016-07-06 | 2019-03-15 | 度瑞公司 | 具有药物组成物、屏障层及药物层的口服剂型 |
| WO2021146215A1 (en) | 2020-01-13 | 2021-07-22 | Durect Corporation | Sustained release drug delivery systems with reduced impurities and related methods |
| CA3203561A1 (en) | 2021-01-12 | 2022-07-21 | Adrian Neil Verity | Sustained release drug delivery systems and related methods |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1009230A (en) * | 1972-09-26 | 1977-04-26 | Daiichi Seiyaku Co. | Peptides effecting to the release of sex hormones and a method for preparing the same |
| US3853834A (en) * | 1972-10-19 | 1974-12-10 | Lilly Co Eli | 4-alanine lh-rh analog |
-
1974
- 1974-10-31 SE SE7413710A patent/SE7413710L/xx not_active Application Discontinuation
- 1974-10-31 NL NL7414241A patent/NL7414241A/xx not_active Application Discontinuation
- 1974-10-31 DK DK568274A patent/DK568274A/da unknown
- 1974-10-31 IE IE2241/74A patent/IE40257B1/en unknown
- 1974-10-31 CA CA212,757A patent/CA1030526A/en not_active Expired
- 1974-10-31 DE DE19742451841 patent/DE2451841A1/de not_active Withdrawn
- 1974-10-31 FR FR7436431A patent/FR2249677B1/fr not_active Expired
- 1974-10-31 US US05/519,667 patent/US3992365A/en not_active Expired - Lifetime
- 1974-10-31 JP JP49126036A patent/JPS5088069A/ja active Pending
- 1974-12-31 AU AU74930/74A patent/AU497418B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IE40257L (en) | 1975-05-01 |
| JPS5088069A (enExample) | 1975-07-15 |
| DK568274A (enExample) | 1975-06-23 |
| FR2249677A1 (enExample) | 1975-05-30 |
| AU497418B2 (en) | 1978-12-14 |
| IE40257B1 (en) | 1979-04-25 |
| FR2249677B1 (enExample) | 1978-07-28 |
| AU7493074A (en) | 1976-05-06 |
| CA1030526A (en) | 1978-05-02 |
| DE2451841A1 (de) | 1975-05-07 |
| US3992365A (en) | 1976-11-16 |
| NL7414241A (nl) | 1975-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2024651A1 (en) | High-absorbable transvaginal preparation containing biologically active polypeptide | |
| IT1196916B (it) | Peptidi biologicamente attivi | |
| DK624884D0 (da) | Peptider | |
| CA1030526A (en) | Biologically active amides | |
| NL930103I2 (nl) | Nonapeptide- en decapeptidederivaten van tot afgifte van luteiniserend hormoon aanzettend hormoon, bereiding daarvan en farmaceutische preparaten, di e deze bevatten. | |
| NO871574D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive peptider. | |
| ATE63750T1 (de) | Peptid, dessen herstellung und benutzung. | |
| GB1557076A (en) | Psychopharmacologically active peptides and peptide derivatives and the use thereof | |
| IL91317A0 (en) | New antibiotic,mersacidin,a process for the preparation thereof and the use thereof as a pharmaceutical | |
| ATE90359T1 (de) | Peptide. | |
| NL7607683A (nl) | Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan. | |
| AU503998B2 (en) | Peptides and peptide synthesis | |
| GB1109086A (en) | Polypeptides | |
| JPS51118739A (en) | Preparation of ll33*3*4 dihydroxyyphenyl**22methyll alanine peptide | |
| IT1149234B (it) | Procedimento per la preparazione di peptidi aciclici aventi attivita' terapeutica | |
| ES2063332T3 (es) | Solucion de infusion nefroprotectora. | |
| DE69227517D1 (de) | Produktion von peptid-amiden | |
| GB1509745A (en) | Pharmaceutically active polypeptides | |
| IL38546A0 (en) | A process for the preparation of new complexes of biologically active peptides,polypeptides,proteins or derivatives or salts thereof having prolonged and/or increased activity | |
| ATE92078T1 (de) | Pharmakologisch aktive peptide. | |
| GB1329869A (en) | Tetracycline derivatives | |
| ATE59393T1 (de) | Peptide. | |
| GB8718325D0 (en) | Peptides & peptid derivatives | |
| DE3869939D1 (de) | Biologisch wirksame peptide. | |
| AU1371376A (en) | Preparation ofd-carbamoyl amino acids aid corresponding d-amino acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 7413710-0 |